| 50090-4513-00 | Glycopyrrolate InjectionA-S Medication Solutions | 1 × 1 | 2 | 2 | $0.66 | ASP | Q3 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 50090-5226-00 | Glycopyrrolate InjectionA-S Medication Solutions | 1 × 25 | 2 | 50 | $16.50 | ASP | Q3 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 62332-0607-25 | Glycopyrrolate InjectionAlembic Pharmaceuticals Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q4 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 62332-0627-25 | Glycopyrrolate InjectionAlembic Pharmaceuticals Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q4 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 62332-0628-25 | Glycopyrrolate InjectionAlembic Pharmaceuticals Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 62332-0629-10 | Glycopyrrolate InjectionAlembic Pharmaceuticals Inc. | 20 × 10 | 40 | 400 | $132.00 | ASP | Q3 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00517-4601-25 | Glycopyrrolate InjectionAmerican Regent, Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00517-4602-25 | Glycopyrrolate InjectionAmerican Regent, Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00517-4605-25 | Glycopyrrolate InjectionAmerican Regent, Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00517-4620-25 | Glycopyrrolate InjectionAmerican Regent, Inc. | 20 × 25 | 40 | 1,000 | $330.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70121-1698-07 | Glycopyrrolate InjectionAmneal Pharmaceuticals, LLC | 1 × 10 | 2 | 20 | $6.60 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70121-1699-07 | Glycopyrrolate InjectionAmneal Pharmaceuticals, LLC | 2 × 10 | 4 | 40 | $13.20 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 60505-6179-05 | Glycopyrrolate InjectionApotex Corp | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 60505-6180-05 | Glycopyrrolate InjectionApotex Corp | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 60505-6181-05 | Glycopyrrolate InjectionApotex Corp | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 60505-6182-04 | Glycopyrrolate InjectionApotex Corp | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 70860-0781-01 | Glycopyrrolate InjectionAthenex Pharmaceutical Division, LLC | 1 × 25 | 2 | 50 | $16.50 | ASP | Q2 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 70860-0781-02 | Glycopyrrolate InjectionAthenex Pharmaceutical Division, LLC | 2 × 25 | 4 | 100 | $33.00 | ASP | Q4 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 70860-0781-05 | Glycopyrrolate InjectionAthenex Pharmaceutical Division, LLC | 5 × 25 | 10 | 250 | $82.50 | ASP | Q2 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 70860-0781-20 | Glycopyrrolate InjectionAthenex Pharmaceutical Division, LLC | 20 × 10 | 40 | 400 | $132.00 | ASP | Q2 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 71839-0123-25 | Glycopyrrolate InjectionBE Pharmaceuticals Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71839-0124-25 | Glycopyrrolate InjectionBE Pharmaceuticals Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71839-0125-25 | Glycopyrrolate InjectionBE Pharmaceuticals Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 72572-0225-25 | Glycopyrrolate InjectionCivica, Inc. | 1 × 25 | 2 | 25 | $8.25 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 72572-0226-25 | Glycopyrrolate InjectionCivica, Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 63323-0578-01 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 63323-0578-02 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 63323-0578-05 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 63323-0578-11 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 63323-0578-12 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 65219-0801-01 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 76045-0203-10 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 1 × 24 | 2 | 48 | $15.84 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 76045-0203-20 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 2 × 24 | 4 | 96 | $31.68 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 76045-0206-10 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 1 × 24 | 2 | 48 | $15.84 | ASP | Q1 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 76045-0208-20 | Glycopyrrolate InjectionFreseniUS Kabi USA, LLC | 2 × 24 | 4 | 96 | $31.68 | ASP | Q4 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00404-9775-01 | Glycopyrrolate InjectionHenry Schein Inc. | 1 × 1 | 2 | 2 | $0.66 | ASP | Q2 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00404-9776-05 | Glycopyrrolate InjectionHenry Schein Inc. | 5 × 1 | 10 | 10 | $3.30 | ASP | Q2 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00404-9777-20 | Glycopyrrolate InjectionHenry Schein Inc. | 20 × 1 | 40 | 40 | $13.20 | ASP | Q2 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00404-9782-02 | Glycopyrrolate InjectionHenry Schein Inc. | 2 × 1 | 4 | 4 | $1.32 | ASP | Q4 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00404-9867-01 | Glycopyrrolate InjectionHenry Schein Inc. | 1 × 1 | 2 | 2 | $0.66 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 00404-9868-20 | Glycopyrrolate InjectionHenry Schein Inc. | 20 × 1 | 40 | 40 | $13.20 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 00404-9869-02 | Glycopyrrolate InjectionHenry Schein Inc. | 2 × 1 | 4 | 4 | $1.32 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 00404-9870-05 | Glycopyrrolate InjectionHenry Schein Inc. | 5 × 1 | 10 | 10 | $3.30 | ASP | Q1 2024 – Q4 2026 | Excluded listingGlycopyrrolate |
|---|
| 51662-1487-01 | Glycopyrrolate InjectionHF Acquisition Co. LLC, DBA HealthFirst | 1 × 1 | 2 | 2 | $0.66 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 51662-1487-03 | Glycopyrrolate InjectionHF Acquisition Co. LLC, DBA HealthFirst | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 51662-1554-03 | Glycopyrrolate InjectionHF Acquisition Co. LLC, DBA HealthFirst | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 51662-1601-01 | Glycopyrrolate InjectionHF Acquisition Co. LLC, DBA HealthFirst | 5 × 1 | 10 | 10 | $3.30 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 51662-1601-03 | Glycopyrrolate InjectionHF Acquisition Co. LLC, DBA HealthFirst | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9584-10 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9585-25 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9586-25 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9587-25 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9679-10 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9680-25 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9681-25 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00143-9682-25 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00641-6212-10 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 1 × 10 | 2 | 20 | $6.60 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00641-6213-10 | Glycopyrrolate InjectionHikma Pharmaceuticals USA Inc. | 2 × 10 | 4 | 40 | $13.20 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0414-03 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0414-04 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0414-92 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0414-94 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0415-06 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0415-21 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 71288-0415-96 | Glycopyrrolate InjectionMeitheal Pharmaceuticals Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q2 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 66794-0202-42 | Glycopyrrolate InjectionPiramal Critical Care Inc | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 66794-0203-42 | Glycopyrrolate InjectionPiramal Critical Care Inc | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 66794-0204-42 | Glycopyrrolate InjectionPiramal Critical Care Inc | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 66794-0205-41 | Glycopyrrolate InjectionPiramal Critical Care Inc | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 25021-0796-01 | Glycopyrrolate InjectionSagent Pharmaceuticals | 1 × 25 | 2 | 50 | $16.50 | ASP | Q3 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 25021-0796-02 | Glycopyrrolate InjectionSagent Pharmaceuticals | 2 × 25 | 4 | 100 | $33.00 | ASP | Q3 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 25021-0796-05 | Glycopyrrolate InjectionSagent Pharmaceuticals | 5 × 25 | 10 | 250 | $82.50 | ASP | Q3 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00781-3825-96 | Glycopyrrolate InjectionSandoz Inc. | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00781-3827-96 | Glycopyrrolate InjectionSandoz Inc. | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00781-3829-96 | Glycopyrrolate InjectionSandoz Inc. | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 00781-3831-95 | Glycopyrrolate InjectionSandoz Inc. | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70069-0616-10 | Glycopyrrolate InjectionSomerset Pharma, LLC | 20 × 10 | 40 | 400 | $132.00 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70069-0617-25 | Glycopyrrolate InjectionSomerset Pharma, LLC | 1 × 25 | 2 | 50 | $16.50 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70069-0618-25 | Glycopyrrolate InjectionSomerset Pharma, LLC | 2 × 25 | 4 | 100 | $33.00 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70069-0619-25 | Glycopyrrolate InjectionSomerset Pharma, LLC | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70700-0165-25 | Glycopyrrolate InjectionXiromed, LLC | 1 × 25 | 2 | 50 | $16.50 | ASP | Q4 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70700-0166-25 | Glycopyrrolate InjectionXiromed, LLC | 2 × 25 | 4 | 100 | $33.00 | ASP | Q4 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70700-0167-25 | Glycopyrrolate InjectionXiromed, LLC | 5 × 25 | 10 | 250 | $82.50 | ASP | Q4 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70700-0168-23 | Glycopyrrolate InjectionXiromed, LLC | 20 × 10 | 40 | 400 | $132.00 | ASP | Q3 2025 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70700-0902-25 | Glycopyrrolate InjectionXiromed, LLC | 5 × 25 | 10 | 250 | $82.50 | ASP | Q1 2026 – Q4 2026 | ListedGlycopyrrolate |
|---|
| 70700-0903-23 | Glycopyrrolate InjectionXiromed, LLC | 20 × 10 | 40 | 400 | $132.00 | ASP | Q4 2024 – Q4 2026 | ListedGlycopyrrolate |
|---|